FDA Inspection 1175133 - AstraZeneca Pharmaceuticals LP - July 22, 2022

Record Details

This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on July 22, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: AstraZeneca Pharmaceuticals LP
Inspection Date: July 22, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · dae5e2be-5942-4a41-b4a5-3f7bf88d2245

Violation Codes3

21 CFR 211.113(b)21 CFR 211.19221 CFR 211.63

Full citation text and observation details available on the Dashboard.